The Registration of Medical Device in FDA, EU and CDSCO: Overview

This comprehensive summary provides a detailed look into the regulatory processes for registering medical devices in three major jurisdictions: the US Food and Drug Administration (FDA), the European Union (EU), and India's Central Drugs Standard Control Organization (CDSCO). Each regulatory agency plays a crucial role in ensuring the safety, effectiveness, and quality standards of medical devices in their respective markets. The FDA, as the regulatory authority in the United States, has a stringent registration system in place to evaluate and approve medical devices before they can be marketed and sold. Manufacturers must adhere to specific procedures and programs to comply with FDA regulations, which are designed to safeguard patient health and promote innovation in the medical device industry. In the European Union, medical device registration is regulated by the EU's Medicinal Products for Human Use Directive, which sets forth stringent requirements for safety and quality standards. Manufacturers must undergo a thorough review process and obtain a CE Mark certification before their devices can be introduced to the European market. The EU's regulatory framework aims to harmonize standards across member states and ensure consistency in device registration procedures. In India, the CDSCO oversees the registration of medical devices and plays a key role in evaluating the safety and efficacy of products before they can be launched in the Indian market. Manufacturers must comply with CDSCO regulations and submit detailed documentation to demonstrate the safety and performance of their devices.

Authors

Institutions

Publication Details

Journal
Journal of Advances in Medical and Pharmaceutical Sciences
Published
2024-08-20
DOI
https://doi.org/10.9734/jamps/2024/v26i8709
Citations
3
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.98
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Registration of Medical Device in FDA, EU and CDSCO: Overview

S. Nagalakshmi, S. Priyadharshini, P. S. Sivaranjani
3 citations
Journal of Advances in Medical and Pharmaceutical Sciences
Biomedical Ethics and Regulation
0.98
article

The Registration of Medical Device in FDA, EU and CDSCO: Overview

S. Nagalakshmi, S. Priyadharshini, P. S. Sivaranjani
article en
3 citations

Abstract

This comprehensive summary provides a detailed look into the regulatory processes for registering medical devices in three major jurisdictions: the US Food and Drug Administration (FDA), the European Union (EU), and India's Central Drugs Standard Control Organization (CDSCO). Each regulatory agency plays a crucial role in ensuring the safety, effectiveness, and quality standards of medical devices in their respective markets. The FDA, as the regulatory authority in the United States, has a stringent registration system in place to evaluate and approve medical devices before they can be marketed and sold. Manufacturers must adhere to specific procedures and programs to comply with FDA regulations, which are designed to safeguard patient health and promote innovation in the medical device industry. In the European Union, medical device registration is regulated by the EU's Medicinal Products for Human Use Directive, which sets forth stringent requirements for safety and quality standards. Manufacturers must undergo a thorough review process and obtain a CE Mark certification before their devices can be introduced to the European market. The EU's regulatory framework aims to harmonize standards across member states and ensure consistency in device registration procedures. In India, the CDSCO oversees the registration of medical devices and plays a key role in evaluating the safety and efficacy of products before they can be launched in the Indian market. Manufacturers must comply with CDSCO regulations and submit detailed documentation to demonstrate the safety and performance of their devices.

Journal of Advances in Medical and Pharmaceutical SciencesVol. 26(8)
Sri Ramachandra Institute of Higher Education and Research (IN)
Partnerships for the goals
Openalex Percentile: Top 24%
Biomedical Ethics and Regulation
0.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.